“…Over the last few years, various organometallic and metal–organic compounds have been used as MgO CVD precursors, including [Mg( η 5 -C 5 H 4 R) 2 ] (R = H, 20 R = Me ( ref. 21 )), [Mg(β-diketonate) 2 ] (β-diketonate = acac, 22 thd 22,23 ), [Mg(β-diketonate) 2 (tmeda)] (β-diketonate = thd, 3,24 = hfac 1 ), [Mg(O 2 CR) 2 ] (R = C 7 H 15 , CNEt 2 ), 25 [Mg 4 Me 4 (O t Bu) 4 ], 26 [Mg 6 (O 2 CNEt 2 ) 12 ], 27 [Mg(DMADB) 2 ] 6 , and [bis[5- N -( N , N -dimethylaminopropyl)-2,2,7-trimethyl-3-octanonato] magnesium] 28 (acac = acetylacetonate, thd = 2,2,6,6-tetramethyl-3,5-heptanedionate, hfac = 1,1,1,5,5,5-hexafluoro-2,4-pentanedionate, tmeda = N , N , N ′, N ′-tetramethylethylenediamine, DMADB = N , N -dimethylaminodiboranate). Among them, the magnesium β-diketonates are very promising CVD precursors, due to their ability to fulfill the requirements needed for gas-phase deposition experiments, which are, for example, high stability and cost-effective and straightforward high yield synthetic methodologies.…”